您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

peptic ulcer drugs market report

健康网讯：

Mareket research report of drugs for peptic ulcer (2007 edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  May 2007
Format:  Adobe PDF
Price:  US$ 2,000
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com 
 
Table of contents
Summary
Fist part: Categories and their definitions of drugs
1 Classification of stomach diseases and the epidemic trend
2 Classifications of chemical drugs for stomach diseases
  2.1 Drugs for peptic ulcer
  2.2 Gastroprokinetic drugs
  2.3 digestant (promoting digestion)
  2.4 antiemetic drug

Second part：Sales statistic in sample hospitals
1 Market scale and growth trend of drugs for stomach diseases
2 Market scale and growth trend of drugs for peptic ulcer in the past
  2.1 Market scale and growth trend from 2002 to 2006
  2.2 Market shares of different categories from 2002 to 2006
  2.3 Sales values of different categories from 2002 to 2006
2.1 Market scale and growth trend 2002～2006
  2.2 Market shares of different categories 2002～2006
  2.3 Structure of breeds or brands of different categories 2002～2006
     Proton Pump Inhibitors(PPI)
     H2-receptor antagonists(H2RA)
     gastric mucosa protective agent
     Gastric acid neutralization agent
     Others
  2.4 Sales analysis of key breeds last year
     2.4.1 Proton Pump Inhibitors(PPI)
        Omeprazole
        Esomeprazole
        Pantoprazol
        Lansoprazole
        Rabeprazole Sodium
    2.4.2 H2-receptor antagonists
        Famotidine
        Cimetidine
        Ranitidine+Citric Acid
        Ranitidine
        Nizatidine
    2.4.3 gastric mucosa protective agent
    2.4.4 Gastric acid neutralization agent

Third part：Sales statistic of retail market for stomach diseases in 2006
1 Market shares of different categories for stomach diseases
2 Market shares of different brands in key cities

Fourth part:
1 Information of researh and development of new product in the world
  Ilaprazole
  TAK-390MR
  Tenatoprazole
  Leminoprazole
  omeprazole
  others
2 Information of researhing and development in China
  2.1 Domestic and imported drugs on the market
  2.2 Status of application and approval

Appendix
Appendix 1: Reference retail prices of popular stomach drugs
Appendix 2: The products listed in Drug Catalogue of National Basic Medical Insurance
Appendix 3: Infromation of application and approval for stomach drugs

Tables
Table 1 The classfications of drugs for peptic ulcer by action mechanism
Table 2 The classfications of drugs for peptic ulcer by action progress
Table 3 Market shares of different categories for petic ulcer drugs
Table 4 List of gastroprokinetic drugs
Table 5 The classfications of antiemetic drugs
Table 6 Sale and growth of different categories of stomach drugs from 2002 to 2006
Table 7 Sale and growth of drugs for peptic ulcer in sample hospitals from 2002 to 2006
Table 8 Sale situation of different categories of peptic ulcer drugs from 2002 to 2006
Table 9 Sales rank of peptic ulcer drugs from 2002 to 2006
Table 10 Sale and growth of Proton Pump Inhibitors from 2002 to 2006
Table 11 Sale values of different Proton Pump Inhibitors from 2002 to 2006
Table 12 Market shares of key brands of  Proton Pump Inhibitors from 2002 to 2006
Table 13 Growth rates of key brands of  Proton Pump Inhibitors from 2002 to 2006
Table 14 Market share of H2 receptor antagnists from 2002 to 2006
Table 15 Sale and growth of gastric mucosa protective agents from 2002 to 2006
Table 16 Sale and growth of gastric acid neutralization agents from 2002 to 2006
Table 17 Sale and growth of other drugs for peptic ulcer from 2002 to 2006
Table 18 37Market shares of key drugs for peptic ulcer in 2006
Table 19 Sales rank of Proton Pump Inhibitors in 2006
Table 20 Market shares of key Proton Pump Inhibitors in 2006
Table 21 Market shares of different enterprises for Omeprazole in 2006
Table 22 Sale and growth of different enterprises for Omeprazole from 2002 to 2006
Table 23 Sales values of Omeprazole with different specifications and administration ways from 2003 to 2006
Table 24 Market shares of different enterprises for Pantoprazol in 2006
Table 25 Sales values of Pantoprazol with different specifications and administration ways from 2003 to 2006
Table 26 Market shares of different enterprises for Lansoprazole in 2006
Table 27 Market shares of different enterprises for Rabeprazole in 2006
Table 28 Market shares of different enterprises for Famotidine in 2006
Table 29 Market shares of different enterprises for Cimetidine in 2006
Table 30 Market shares of different enterprises for Ranitidine+Citric Acid in 2006
Table 31 Market shares of different enterprises for Ranitidine in 2006
Table 32 The enterprise with the approval number of Nizatidine approved by SFDA
Table 33 Market shares of different enterprises for gastric mucosa protective agent in 2006
Table 34 Market shares of different enterprises for Bismuth Potassium Citrate in 2006
Table 35 Market shares of different enterprises for Sucralfate in 2006
Table 36 Market shares of different enterprises for compound Glutamine in 2006
Table 37 Market shares of different enterprises for Misoprostol in 2006
Table 38 Market shares of different enterprises for Gastric acid neutralization agent in 2006
Table 39 Market shares of different enterprises for Hydrotalcite in 2006
Table 40 Market shares of different enterprises for Aluminum Phosphate gel in 2006
Table 41 Market shares of different enterprises for Calcium Carbonate in 2006
Table 42 Sales rank of retail drugs for gastrointestinal diseases in Shanghai in 2006
Table 43 Sales rank of enterprises in retail market of gastrointestinal drugs in Shanghai in 2006
Table 44 Sales rank of retail drugs for gastrointestinal diseases in Shenyang in 2006
Table 45 Sales rank of enterprises in retail market of gastrointestinal drugs in Shenyang in 2006
Table 46 Sales rank of retail drugs for gastrointestinal diseases in Qingdao in 2006
Table 47 Sales rank of enterprises in retail market of gastrointestinal drugs in Qingdao in 2006
Table 48 The amount of enterprises producing stomach drugs
Table 49 Products under the examination and approval by SFDA
Table 50 Reail prices of polualr stomach drugs
Table 51 List of the products in Drug Catalogue of National Basic Medical Insurance
Table 52 The drugs added to B class Drug Catalogue of National Basic Medical Insurance by province health deapartment

(There are 48 figures in the reports)